GuilhermeAttizzaniMD
Cardiology • Cleveland, OHDirector, Valve and Structural Heart Disease Center, Harrington Heart and Vascular Institute, University Hospitals
Dr. Attizzani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-3800
Certifications & Licensure
OH State Medical License 2014 - 2023
Clinical Trials
- ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement Start of enrollment: 2019 Jun 10
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 46 citationsTemporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stentsGiulio Guagliumi, Kunihiro Shimamura, Vasile Sirbu, Roberto Garbo, Giacomo Boccuzzi
European Heart Journal. 2018-07-07 - 47 citationsFailure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent ThrombosisDaisuke Nakamura, Guilherme F. Attizzani, Catalin Toma, Tej Sheth, Wei Wang
Circulation. Cardiovascular Interventions. 2016-09-01 - 247 citations1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular CalcificationMayra Guerrero, Marina Urena, Dominique Himbert, Dee Dee Wang, Mackram F. Eleid
Journal of the American College of Cardiology. 2018-05-01
Journal Articles
- Focus on Coronary Physiology New Volumetric Analysis Method for Stent Expansion and Its Correlation with Final Fractional Flow Reserve and Clinical Outcome: An ILUMIEN...Sandeep M Patel, Matthew J Price, Michael R Jones, Guilherme F Attizzani, ScienceDirect
Authored Content
- Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement with a Self-Expandable ValveAugust 2020
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
- 1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
Press Mentions
TAVR: Favorable Hemodynamics with Evolut PROJune 20th, 2020
University Hospitals Completes First Evolut™ PRO+ Case in the WorldJanuary 24th, 2020
Medtronic Launches Evolut Pro+ TAVR System: Interview with Dr. Pieter KappeteinOctober 15th, 2019- Join now to see all
Other Languages
- Spanish, Italian, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
